Alice Liu, MD
Endocrinology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A87988 · Current
Licensed to practise in California · since 2004 · expires 2028-07-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$147,586
Medicare paid this office $147,586 for 283 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 40 | $80,772 | None |
| Return visit (30+ min) | 208 | $34,132 | $108 |
| Long return visit (40+ min) | 67 | $12,145 | $152 |
| New patient visit (60+ min) | 22 | $4,184 | $190 |
| Short return visit (20+ min) | 36 | $3,506 | $76 |
See all 8 services
| Injection, denosumab, 1 mg | 40 | $80,772 | None |
| Return visit (30+ min) | 208 | $34,132 | $108 |
| Long return visit (40+ min) | 67 | $12,145 | $152 |
| New patient visit (60+ min) | 22 | $4,184 | $190 |
| Short return visit (20+ min) | 36 | $3,506 | $76 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 151 | $2,737 | $15 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 41 | $2,349 | $31 |
| Injection of drug or substance under skin or into muscle | 43 | $1,011 | $14 |
Who their Medicare patients are
283 Original Medicare patients in 2024. Average age 76 · Women 72% · Also on Medicaid 5% · Health risk score 1.16. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 64% · Diabetes 37% · Coronary heart disease 27% · Chronic kidney disease 27% · Cancer 17% · Atrial fibrillation 16% · Depression 15% · Heart failure 11% · COPD 10% · Dementia 4%.
The office billed $420,553, Medicare allowed $194,170 and paid $147,586; for 4,994 services of 18 kinds; $85,807 of it was for drugs given in the office and $61,779 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 283 | 4,994 | 76 | 1.16 | $420,553 | $147,586 |
| 2023 | 303 | 4,645 | 76 | 1.18 | $401,362 | $138,607 |
| 2022 | 301 | 4,326 | 75 | 1.09 | $385,039 | $126,417 |
| 2021 | 262 | 3,669 | 75 | 1.20 | $313,347 | $107,141 |
| 2020 | 231 | 4,160 | 74 | 1.19 | $230,487 | $74,439 |
| 2019 | 244 | 4,124 | 74 | 1.09 | $266,061 | $77,113 |
| 2018 | 200 | 1,751 | 74 | 1.10 | $209,370 | $56,390 |
| 2017 | 178 | 1,200 | 74 | 1.02 | $165,105 | $44,098 |
| 2016 | 205 | 1,579 | 74 | 1.00 | $182,440 | $51,657 |
| 2015 | 15 | 79 | 68 | 0.97 | $8,952 | $2,571 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Injection, denosumab, 1 mg | 37 | $69,848 | None |
| Return visit (30+ min) | 199 | $34,787 | $110 |
| Long return visit (40+ min) | 84 | $16,979 | $165 |
| New patient visit (60+ min) | 18 | $3,121 | $173 |
| Short return visit (20+ min) | 30 | $2,473 | $73 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 41 | $2,473 | $31 |
| Injection of drug or substance under skin or into muscle | 40 | $960 | $14 |
2022: 8 services
| Injection, denosumab, 1 mg | 35 | $62,287 | None |
| Return visit (30+ min) | 200 | $30,625 | $103 |
| Long return visit (40+ min) | 85 | $16,950 | $154 |
| New patient visit (60+ min) | 25 | $4,603 | $184 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 37 | $2,280 | $30 |
| Short return visit (20+ min) | 21 | $1,673 | $70 |
| New patient visit (45+ min) | 11 | $1,407 | $128 |
| Injection of drug or substance under skin or into muscle | 38 | $1,283 | $14 |
2021: 8 services
| Injection, denosumab, 1 mg | 31 | $51,271 | None |
| Return visit (30+ min) | 140 | $22,907 | $107 |
| Long return visit (40+ min) | 88 | $17,037 | $161 |
| New patient visit (60+ min) | 31 | $5,756 | $186 |
| New patient visit (45+ min) | 22 | $3,012 | $137 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 29 | $1,582 | $31 |
| Short return visit (20+ min) | 15 | $1,404 | $83 |
| Injection of drug or substance under skin or into muscle | 33 | $894 | $14 |
2020: 9 services
| Injection, denosumab, 1 mg | 24 | $36,038 | None |
| Return visit (30+ min) | 113 | $14,125 | $96 |
| New patient visit (45+ min) | 40 | $5,183 | $130 |
| Short return visit (20+ min) | 64 | $4,732 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 26 | $3,565 | $105 |
| Long return visit (40+ min) | 21 | $3,163 | $132 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,011 | $67 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 15 | $840 | $30 |
| Injection of drug or substance under skin or into muscle | 27 | $686 | $13 |
2019: 7 services
| Injection, denosumab, 1 mg | 22 | $32,016 | None |
| Return visit (30+ min) | 111 | $15,730 | $95 |
| Short return visit (20+ min) | 121 | $11,667 | $60 |
| New patient visit (45+ min) | 56 | $7,881 | $141 |
| Long return visit (40+ min) | 17 | $2,334 | $130 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 17 | $1,201 | $30 |
| Injection of drug or substance under skin or into muscle | 25 | $872 | $16 |
2018: 8 services
| Injection, denosumab, 1 mg | 17 | $17,633 | None |
| Short return visit (20+ min) | 115 | $11,130 | $59 |
| Return visit (30+ min) | 73 | $10,362 | $90 |
| New patient visit (45+ min) | 58 | $7,840 | $135 |
| Fine needle aspiration using imaging guidance | 11 | $1,339 | $122 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 11 | $901 | $32 |
| Injection of drug or substance under skin or into muscle | 20 | $729 | $20 |
| Ultrasonic guidance for needle placement | 11 | $520 | $47 |
2017: 5 services
| Injection, denosumab, 1 mg | 12 | $10,235 | None |
| Short return visit (20+ min) | 94 | $9,815 | $63 |
| Return visit (30+ min) | 77 | $9,796 | $91 |
| New patient visit (45+ min) | 61 | $7,994 | $131 |
| Injection of drug or substance under skin or into muscle | 14 | $644 | $26 |
2016: 8 services
| New patient visit (45+ min) | 107 | $15,462 | $145 |
| Injection, denosumab, 1 mg | 16 | $14,902 | None |
| Return visit (30+ min) | 76 | $8,104 | $93 |
| Short return visit (20+ min) | 52 | $5,070 | $66 |
| Fine needle aspiration using imaging guidance | 11 | $1,678 | $140 |
| New patient visit (30+ min) | 16 | $1,528 | $96 |
| Injection of drug or substance under skin or into muscle | 19 | $941 | $25 |
| Ultrasonic guidance for needle placement | 11 | $712 | $59 |
Medicaid work
$66 in 2022
Medicaid paid $66 for 12 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $66 |
| 2022 | 12 | 1 | 12 | $66 |
Drugs they prescribed that Part D paid
$954,372
Pharmacies billed $954,372 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,970) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
879 generic and 991 brand-name prescriptions · $954,372 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 162 | $233,844 | $1,443 |
| Jardiance | 135 | $180,373 | $1,336 |
| Trulicity | 101 | $148,668 | $1,472 |
| Mounjaro | 40 | $48,614 | $1,215 |
| Teriparatide | 18 | $46,019 | $2,557 |
See all 37 drugs
| Ozempic | 162 | $233,844 | $1,443 |
| Jardiance | 135 | $180,373 | $1,336 |
| Trulicity | 101 | $148,668 | $1,472 |
| Mounjaro | 40 | $48,614 | $1,215 |
| Teriparatide | 18 | $46,019 | $2,557 |
| Rybelsus | 20 | $29,338 | $1,467 |
| Tresiba Flextouch U-100 | 33 | $25,454 | $771 |
| Januvia | 19 | $21,691 | $1,142 |
| Humalog Kwikpen U-100 | 30 | $11,333 | $378 |
| Tirosint | 45 | $11,139 | $248 |
| Synthroid | 91 | $9,067 | $100 |
| Lantus Solostar | 40 | $7,072 | $177 |
| Humalog | 14 | $5,237 | $374 |
| Nano 2nd Gen Pen Needle | 43 | $4,897 | $114 |
| Risedronate | 34 | $4,067 | $120 |
| Insulin Lispro Kwikpen U-100 | 14 | $4,062 | $290 |
| Novolog Mix 70-30 Flexpen | 11 | $3,338 | $303 |
| Metformin Hcl Er | 128 | $2,652 | $21 |
| Levothyroxine | 213 | $2,369 | $11 |
| Ultra-Fine Short Pen Needle | 14 | $2,326 | $166 |
| Ultra-Fine Mini Pen Needle | 24 | $2,116 | $88 |
| Ultra-Fine Nano Pen Needle | 13 | $1,918 | $148 |
| Repaglinide | 29 | $1,357 | $47 |
| Alendronate | 142 | $1,199 | $8 |
| Glipizide Er | 36 | $868 | $24 |
| Rosuvastatin | 25 | $785 | $31 |
| Insulin Glargine-Yfgn | 12 | $750 | $63 |
| Levoxyl | 14 | $747 | $53 |
| Atorvastatin | 64 | $626 | $10 |
| Metformin | 50 | $443 | $9 |
| Glipizide | 14 | $400 | $29 |
| Liothyronine | 12 | $308 | $26 |
| Methimazole | 29 | $305 | $11 |
| Glimepiride | 11 | $264 | $24 |
| Lisinopril | 17 | $209 | $12 |
| Testosterone Cypionate | 11 | $182 | $17 |
| Hydrochlorothiazide | 15 | $84 | $6 |
Year by year
| 2024 | 1,970 | 265 | 0% (0) | 50% | $954,372 |
| 2023 | 1,795 | 251 | 0% (0) | 50% | $994,682 |
| 2022 | 1,691 | 231 | 0% (0) | 50% | $837,963 |
| 2021 | 1,466 | 207 | 0% (0) | 45% | $643,934 |
| 2020 | 1,432 | 176 | 0% (0) | 43% | $541,340 |
| 2019 | 1,368 | 170 | 0% (0) | 45% | $472,845 |
| 2018 | 1,104 | 155 | 0% (0) | 44% | $347,099 |
| 2017 | 849 | 132 | 0% (0) | 38% | $221,841 |
| 2016 | 414 | 102 | 0% (0) | 37% | $90,542 |
| 2015 | 11 | 11 | 0% (0) | None | $2,269 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Trulicity | 138 | $219,770 | $1,593 |
| Ozempic | 96 | $185,238 | $1,930 |
| Jardiance | 134 | $163,082 | $1,217 |
| Tymlos | 16 | $43,421 | $2,714 |
| Humalog Kwikpen U-100 | 33 | $36,065 | $1,093 |
| Lantus Solostar | 42 | $31,153 | $742 |
| Humalog | 14 | $28,105 | $2,008 |
| Tresiba Flextouch U-100 | 37 | $26,523 | $717 |
| Farxiga | 14 | $15,051 | $1,075 |
| Tirosint | 52 | $13,935 | $268 |
| Metformin Er Osmotic | 12 | $13,378 | $1,115 |
| Synthroid | 93 | $11,161 | $120 |
| Nano 2nd Gen Pen Needle | 45 | $5,062 | $112 |
| Risedronate | 50 | $4,389 | $88 |
| Metformin Hcl Er | 116 | $2,907 | $25 |
| Ultra-Fine Nano Pen Needle | 25 | $2,731 | $109 |
| Testosterone | 11 | $2,400 | $218 |
| Levothyroxine | 145 | $2,211 | $15 |
| Ultra-Fine Short Pen Needle | 11 | $2,106 | $191 |
| Ultra-Fine Mini Pen Needle | 25 | $2,093 | $84 |
| Repaglinide | 15 | $1,656 | $110 |
| Glipizide Er | 45 | $1,593 | $35 |
| Alendronate | 105 | $1,529 | $15 |
| Metformin | 62 | $896 | $14 |
| Atorvastatin | 57 | $669 | $12 |
| Nateglinide | 12 | $641 | $53 |
| Levoxyl | 14 | $639 | $46 |
| Insulin Lispro | 12 | $527 | $44 |
| Glipizide | 14 | $286 | $20 |
| Methimazole | 32 | $250 | $8 |
| Glimepiride | 13 | $219 | $17 |
| Losartan | 13 | $196 | $15 |
| Hydrochlorothiazide | 18 | $190 | $11 |
| Lisinopril | 17 | $167 | $10 |
2022: 40 drugs
| Trulicity | 130 | $178,654 | $1,374 |
| Jardiance | 114 | $120,459 | $1,057 |
| Ozempic | 47 | $95,037 | $2,022 |
| Lantus Solostar | 49 | $36,247 | $740 |
| Humalog Kwikpen U-100 | 27 | $31,463 | $1,165 |
| Teriparatide | 11 | $28,929 | $2,630 |
| Humalog | 14 | $23,407 | $1,672 |
| Januvia | 14 | $20,932 | $1,495 |
| Tresiba Flextouch U-100 | 30 | $17,661 | $589 |
| Farxiga | 15 | $17,382 | $1,159 |
| Metformin Er Osmotic | 12 | $16,886 | $1,407 |
| Baqsimi | 22 | $12,810 | $582 |
| Lantus | 29 | $11,216 | $387 |
| Tirosint | 41 | $9,871 | $241 |
| Synthroid | 71 | $7,619 | $107 |
| Insulin Lispro Kwikpen U-100 | 13 | $2,927 | $225 |
| Nano 2nd Gen Pen Needle | 31 | $2,685 | $87 |
| Glipizide Er | 61 | $2,681 | $44 |
| Ultra-Fine Nano Pen Needle | 25 | $2,598 | $104 |
| Ultra-Fine Short Pen Needle | 14 | $2,549 | $182 |
| Levothyroxine | 122 | $2,231 | $18 |
| Risedronate | 33 | $2,034 | $62 |
| Metformin Hcl Er | 91 | $1,556 | $17 |
| Alendronate | 121 | $1,480 | $12 |
| Ultra-Fine Mini Pen Needle | 18 | $1,451 | $81 |
| Repaglinide | 11 | $1,121 | $102 |
| Hydrocortisone | 12 | $1,080 | $90 |
| Insulin Lispro | 12 | $980 | $82 |
| Testosterone | 11 | $956 | $87 |
| Levoxyl | 16 | $886 | $55 |
| Nateglinide | 12 | $833 | $69 |
| Atorvastatin | 57 | $715 | $13 |
| Methimazole | 40 | $545 | $14 |
| Metformin | 51 | $524 | $10 |
| Lisinopril | 15 | $253 | $17 |
| Glimepiride | 18 | $232 | $13 |
| Glipizide | 18 | $172 | $10 |
| Losartan | 18 | $112 | $6 |
| Hydrochlorothiazide | 15 | $107 | $7 |
| Gabapentin | 12 | $26 | $2 |
2021: 33 drugs
| Trulicity | 78 | $119,825 | $1,536 |
| Jardiance | 60 | $87,165 | $1,453 |
| Ozempic | 39 | $64,289 | $1,648 |
| Tradjenta | 26 | $33,570 | $1,291 |
| Januvia | 21 | $32,205 | $1,534 |
| Lantus Solostar | 46 | $30,848 | $671 |
| Humalog | 14 | $18,117 | $1,294 |
| Farxiga | 14 | $16,917 | $1,208 |
| Humalog Kwikpen U-100 | 18 | $16,581 | $921 |
| Tresiba Flextouch U-100 | 23 | $15,105 | $657 |
| Norditropin Flexpro | 12 | $8,868 | $739 |
| Synthroid | 80 | $7,854 | $98 |
| Lantus | 24 | $7,739 | $322 |
| Tirosint | 40 | $6,877 | $172 |
| Metformin Er Osmotic | 14 | $4,557 | $325 |
| Testosterone | 14 | $3,944 | $282 |
| Ultra-Fine Nano Pen Needle | 32 | $3,050 | $95 |
| Risedronate | 25 | $2,618 | $105 |
| Levothyroxine | 98 | $2,341 | $24 |
| Glipizide Er | 50 | $2,149 | $43 |
| Nano 2nd Gen Pen Needle | 23 | $1,748 | $76 |
| Metformin Hcl Er | 86 | $1,609 | $19 |
| Ultra-Fine Mini Pen Needle | 20 | $1,432 | $72 |
| Alendronate | 103 | $1,307 | $13 |
| Hydrocortisone | 14 | $1,066 | $76 |
| Glimepiride | 28 | $585 | $21 |
| Metformin | 55 | $462 | $8 |
| Atorvastatin | 43 | $407 | $9 |
| Methimazole | 37 | $386 | $10 |
| Glipizide | 21 | $195 | $9 |
| Losartan | 26 | $173 | $7 |
| Lisinopril | 11 | $111 | $10 |
| Hydrochlorothiazide | 12 | $33 | $3 |
2020: 35 drugs
| Jardiance | 69 | $77,994 | $1,130 |
| Januvia | 38 | $51,300 | $1,350 |
| Trulicity | 36 | $48,742 | $1,354 |
| Ozempic | 39 | $40,942 | $1,050 |
| Tradjenta | 39 | $31,612 | $811 |
| Lantus Solostar | 49 | $31,191 | $637 |
| Novolog Mix 70-30 Flexpen | 12 | $19,444 | $1,620 |
| Humalog Kwikpen U-100 | 15 | $16,325 | $1,088 |
| Rybelsus | 11 | $15,385 | $1,399 |
| Novolog | 25 | $12,214 | $489 |
| Tirosint | 38 | $8,432 | $222 |
| Testosterone | 12 | $7,729 | $644 |
| Tresiba Flextouch U-100 | 12 | $6,108 | $509 |
| Synthroid | 48 | $4,838 | $101 |
| Ultra-Fine Nano Pen Needle | 63 | $4,555 | $72 |
| Admelog Solostar | 12 | $3,850 | $321 |
| Glipizide Er | 78 | $2,858 | $37 |
| Metformin Er Osmotic | 12 | $2,311 | $193 |
| Levothyroxine | 88 | $2,213 | $25 |
| Metformin Hcl Er | 90 | $1,623 | $18 |
| Risedronate | 16 | $1,404 | $88 |
| Alendronate | 91 | $1,276 | $14 |
| Ultra-Fine Mini Pen Needle | 18 | $1,150 | $64 |
| Testosterone Cypionate | 12 | $856 | $71 |
| Glimepiride | 22 | $813 | $37 |
| Hydrocortisone | 13 | $772 | $59 |
| Repaglinide | 14 | $748 | $53 |
| Atorvastatin | 46 | $586 | $13 |
| Metformin | 50 | $510 | $10 |
| Methimazole | 32 | $481 | $15 |
| Losartan | 41 | $338 | $8 |
| Glipizide | 26 | $303 | $12 |
| Lisinopril | 11 | $90 | $8 |
| Amlodipine Besylate | 12 | $64 | $5 |
| Hydrochlorothiazide | 11 | $34 | $3 |
2019: 32 drugs
| Jardiance | 76 | $59,492 | $783 |
| Januvia | 45 | $49,092 | $1,091 |
| Tradjenta | 65 | $33,907 | $522 |
| Humalog Kwikpen U-100 | 38 | $32,881 | $865 |
| Novolog Mix 70-30 Flexpen | 22 | $30,465 | $1,385 |
| Trulicity | 21 | $29,419 | $1,401 |
| Lantus Solostar | 37 | $26,413 | $714 |
| Testosterone | 19 | $12,049 | $634 |
| Novolog | 23 | $10,773 | $468 |
| Levemir Flextouch | 14 | $9,108 | $651 |
| Novolog Flexpen | 11 | $7,381 | $671 |
| Lantus | 16 | $5,819 | $364 |
| Ultra-Fine Nano Pen Needle | 59 | $5,231 | $89 |
| Synthroid | 48 | $4,251 | $89 |
| Tirosint | 21 | $3,240 | $154 |
| Risedronate | 23 | $2,564 | $111 |
| Glipizide Er | 46 | $2,378 | $52 |
| Levothyroxine | 94 | $2,345 | $25 |
| Metformin Hcl Er | 70 | $1,654 | $24 |
| Acarbose | 19 | $1,366 | $72 |
| Alendronate | 106 | $1,243 | $12 |
| Hydrocortisone | 23 | $1,066 | $46 |
| Ultra-Fine Mini Pen Needle | 15 | $1,018 | $68 |
| Glimepiride | 29 | $1,008 | $35 |
| Repaglinide | 22 | $745 | $34 |
| Atorvastatin | 38 | $626 | $16 |
| Glipizide | 34 | $460 | $14 |
| Methimazole | 30 | $442 | $15 |
| Metformin | 32 | $370 | $12 |
| Losartan | 24 | $281 | $12 |
| Amlodipine Besylate | 11 | $125 | $11 |
| Hydrochlorothiazide | 12 | $65 | $5 |
2018: 30 drugs
| Novolog Mix 70-30 Flexpen | 19 | $33,645 | $1,771 |
| Januvia | 26 | $29,220 | $1,124 |
| Trulicity | 19 | $23,926 | $1,259 |
| Androgel | 16 | $23,365 | $1,460 |
| Jardiance | 18 | $21,170 | $1,176 |
| Humalog Kwikpen U-100 | 23 | $21,138 | $919 |
| Victoza 3-Pak | 17 | $19,176 | $1,128 |
| Tradjenta | 33 | $15,202 | $461 |
| Levemir Flextouch | 21 | $13,084 | $623 |
| Lantus Solostar | 23 | $12,987 | $565 |
| Novolog | 18 | $10,161 | $564 |
| Lantus | 14 | $6,607 | $472 |
| Ultra-Fine Nano Pen Needle | 63 | $5,515 | $88 |
| Synthroid | 65 | $4,929 | $76 |
| Levothyroxine | 98 | $2,200 | $22 |
| Tirosint | 12 | $1,782 | $148 |
| Ultra-Fine Mini Pen Needle | 21 | $1,614 | $77 |
| Hydrocortisone | 23 | $1,207 | $52 |
| Glimepiride | 30 | $1,016 | $34 |
| Glipizide Er | 33 | $986 | $30 |
| Metformin Hcl Er | 53 | $972 | $18 |
| Alendronate | 76 | $867 | $11 |
| Repaglinide | 14 | $750 | $54 |
| Atorvastatin | 40 | $688 | $17 |
| Glipizide | 45 | $334 | $7 |
| Metformin | 28 | $313 | $11 |
| Methimazole | 19 | $296 | $16 |
| Levoxyl | 15 | $198 | $13 |
| Losartan | 20 | $172 | $9 |
| Lisinopril | 14 | $136 | $10 |
2017: 23 drugs
| Novolog Mix 70-30 Flexpen | 12 | $29,036 | $2,420 |
| Humalog Kwikpen U-100 | 31 | $21,992 | $709 |
| Januvia | 29 | $21,408 | $738 |
| Tradjenta | 17 | $13,343 | $785 |
| Lantus Solostar | 21 | $11,150 | $531 |
| Levemir Flextouch | 16 | $9,679 | $605 |
| Metformin Hcl Er | 38 | $3,483 | $92 |
| Ultra-Fine Nano Pen Needle | 37 | $2,710 | $73 |
| Synthroid | 37 | $2,635 | $71 |
| Levothyroxine | 76 | $1,989 | $26 |
| Bd Ultra-Fine Pen Needle | 11 | $1,650 | $150 |
| Ultra-Fine Mini Pen Needle | 19 | $1,136 | $60 |
| Glimepiride | 32 | $758 | $24 |
| Alendronate | 73 | $639 | $9 |
| Atorvastatin | 28 | $587 | $21 |
| Glipizide Er | 20 | $447 | $22 |
| Metformin | 28 | $385 | $14 |
| Repaglinide | 11 | $352 | $32 |
| Methimazole | 20 | $239 | $12 |
| Glipizide | 34 | $208 | $6 |
| Lisinopril | 20 | $195 | $10 |
| Losartan | 12 | $191 | $16 |
| Hydrocortisone | 11 | $181 | $16 |
2016: 14 drugs
| Androgel | 11 | $14,336 | $1,303 |
| Humalog Kwikpen U-100 | 17 | $10,064 | $592 |
| Levemir Flextouch | 11 | $6,033 | $548 |
| Lantus Solostar | 16 | $5,799 | $362 |
| Metformin Hcl Er | 31 | $4,827 | $156 |
| Bd Ultra-Fine Pen Needle | 37 | $2,529 | $68 |
| Synthroid | 14 | $1,135 | $81 |
| Levothyroxine | 34 | $1,008 | $30 |
| Methimazole | 24 | $532 | $22 |
| Metformin | 15 | $259 | $17 |
| Alendronate | 18 | $245 | $14 |
| Glimepiride | 13 | $196 | $15 |
| Atorvastatin | 18 | $191 | $11 |
| Lisinopril | 16 | $161 | $10 |
Money from drug and device companies
$87 in 2019
A payment is not proof that care is biased.
| Genzyme | Disease State | $87 | 1 payment
|
See the published payment
| Genzyme | Meals · 2019-09-26 | Disease State | $87 |
Professional record
- NPI
- 1841486792
- Licence
- CA A87988California A87988: Current · expires 2028-07-31
- Trained
- University of California, San Francisco School of Medicine, 2003
- Group
- Stanford Health Care · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-09-24
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 325 Distel Cir, Los Altos, CA, 94022 · 301 Industrial Rd, San Carlos, CA, 94070